[
  {
    "ts": null,
    "headline": "Regeneron: Drug Pricing Woes Notwithstanding, Due For A Major Comeback",
    "summary": "Regeneron Pharmaceuticals, Inc.âs pharma pipeline and $20bn revenue potential promise long-term upside, despite a recent stock decline. Click for my REGN update.",
    "url": "https://finnhub.io/api/news?id=8a39405e4d951130013fa158963d88c4997ed419627b299743d82ab91c07f165",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756837853,
      "headline": "Regeneron: Drug Pricing Woes Notwithstanding, Due For A Major Comeback",
      "id": 136609030,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2210182189/image_2210182189.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Regeneron Pharmaceuticals, Inc.âs pharma pipeline and $20bn revenue potential promise long-term upside, despite a recent stock decline. Click for my REGN update.",
      "url": "https://finnhub.io/api/news?id=8a39405e4d951130013fa158963d88c4997ed419627b299743d82ab91c07f165"
    }
  },
  {
    "ts": null,
    "headline": "Evercore ISI Maintains a Buy on Regeneron Pharmaceuticals (REGN) With a $750 PT",
    "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best affordable growth stocks to buy. In a report released on August 27, Cory Kasimov from Evercore ISI maintained a Buy rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), setting a price target of $750.00. On August 26, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) reported that its Cemdisiran monotherapy, dosed subcutaneously […]",
    "url": "https://finnhub.io/api/news?id=0abef1f2ef0345ad269a9ab39d01afae00a486e39080db5a4120935a2639c0a5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756829576,
      "headline": "Evercore ISI Maintains a Buy on Regeneron Pharmaceuticals (REGN) With a $750 PT",
      "id": 136613407,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the best affordable growth stocks to buy. In a report released on August 27, Cory Kasimov from Evercore ISI maintained a Buy rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), setting a price target of $750.00. On August 26, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) reported that its Cemdisiran monotherapy, dosed subcutaneously […]",
      "url": "https://finnhub.io/api/news?id=0abef1f2ef0345ad269a9ab39d01afae00a486e39080db5a4120935a2639c0a5"
    }
  },
  {
    "ts": null,
    "headline": "Merck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector",
    "summary": "DARMSTADT, Germany, September 02, 2025--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for its Healthcare business sector.",
    "url": "https://finnhub.io/api/news?id=9e3cd5534c83bebd1fc03f3ee10da87ecb02dc525c5679b15d07e971f80293bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756818000,
      "headline": "Merck KGaA, Darmstadt, Germany, Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector",
      "id": 136604439,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "DARMSTADT, Germany, September 02, 2025--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for its Healthcare business sector.",
      "url": "https://finnhub.io/api/news?id=9e3cd5534c83bebd1fc03f3ee10da87ecb02dc525c5679b15d07e971f80293bb"
    }
  }
]